Members |
targetComponentId |
Triamcinolone acetonide 40mg injection suspension ampule |
Triamcinolone only product in parenteral dose form |
Triamcinolone acetonide 40mg/mL suspension |
Product containing only triamcinolone (medicinal product) |
Triamcinolone diacetate 25mg/mL injection suspension ampule |
Triamcinolone diacetate 25 mg/mL suspension for injection |
Triamcinolone diacetate 40mg/mL injection suspension ampule |
Product containing precisely triamcinolone diacetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Triazole derivative |
Substance with triazole structure (substance) |
Tribavirin 6g inhalation (pdr for recon) |
Product containing precisely ribavirin 20 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
Tricho-thiodystrophy |
A rare, genetic, syndromic hair shaft abnormality disorder characterised by short, dry, sulphur-deficient, brittle hair usually associated with highly variable neuroectodermal manifestations, such as ichthyosis, photosensitivity, and intellectual disability. |
Trichoglossus haematodos forsteni |
Trichoglossus forsteni (organism) |
Trichomoniasis of other sites |
Infection by Trichomonas |
Trichosporon capitatum |
Magnusiomyces capitatus |
Triclofos sodium allergy |
Allergy to triclofos |
Triclosan 2% bath additive |
Triclosan 20 mg/mL cutaneous solution |
Tricuspid valve regurgitation due to carcinoid tumor |
Tricuspid valve regurgitation due to neuroendocrine tumor (disorder) |
Tricuspid valve stenosis due to carcinoid tumor |
Tricuspid valve stenosis due to neuroendocrine tumour |
Tricuspid valve stenosis with regurgitation due to carcinoid tumor |
Tricuspid valve stenosis with regurgitation due to neuroendocrine tumor (disorder) |
Triethanolamine polypeptide oleate condensate 10% solution |
Product containing only triethanolamine in otic dose form (medicinal product form) |
Trifluoperazine hydrochlorid 1mg tablet |
Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 1 milligram/1 each conventional release oral tablet (clinical drug) |
Trifluoperazine hydrochlorid 5mg tablet |
Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) |
Trifluoperazine hydrochloride 10mg/mL solution |
Trifluoperazine 10 mg/mL oral solution |
Trigeminal nerve disorder NOS |
Trigeminal nerve disorder |
Trigeminal nerve disorder NOS |
Trigeminal nerve disorder |
Trigemino-sympathetic syndrome |
Paratrigeminal syndrome |
Trihexyphenidyl hydrochloride 5mg m/r capsule |
Product containing only trihexyphenidyl in oral dose form (medicinal product form) |
Trihexyphenidyl hydrochloride 5mg prolonged-release oral capsule |
Product containing only trihexyphenidyl in oral dose form (medicinal product form) |
Trimellitic anhydride specific extract |
Trimellitic acid |
Trimesters |
Temporal period relating to mother from conception until the onset of labour. |
Trimethobenzamide 100mg/mL |
Trimethobenzamide hydrochloride 100 mg/mL solution for injection |
Trimethobenzamide hydrochlor 100mg/mL solution |
Trimethobenzamide hydrochloride 100 mg/mL solution for injection |
Trimethobenzamide hydrochloride 100 mg/mL intramuscular solution |
Trimethobenzamide hydrochloride 100 mg/mL solution for injection |
Trimethobenzamide hydrochloride 100mg suppositories |
Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 100 milligram/1 each conventional release rectal suppository (clinical drug) |
Trimethobenzamide hydrochloride 100mg/mL bar |
Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 100 milligram/1 each conventional release rectal suppository (clinical drug) |
Trimethobenzamide hydrochloride 100mg/mL injection solution ampule |
Trimethobenzamide hydrochloride 100 mg/mL solution for injection |
Trimethobenzamide hydrochloride 200mg suppository |
Product containing precisely trimethobenzamide (as trimethobenzamide hydrochloride) 200 milligram/1 each conventional release rectal suppository (clinical drug) |
Trinitrotoluene, device |
Trinitrotoluene (substance) |
Triphalangeal thumbs with onychodystrophy |
A rare multiple congenital anomalies-intellectual disability syndrome characterized by sensorineural hearing loss (deafness), onychodystrophy, osteodystrophy, mild to profound intellectual disability, and seizures. |
Triphosphoric monoester hydrolase |
Triphosphoric monoester hydrolase |
Triprolidine hydrochloride 100% |
Product containing triprolidine (medicinal product) |
Triptorelin pamoate 11.25mg/vial lyophilized powder for conventional release suspension for injection |
Triptorelin only product in parenteral dose form |
Triptorelin pamoate 11.25mg/vial powder |
Triptorelin only product in parenteral dose form |
Triptorelin pamoate 3.75mg/vial lyophilized powder for conventional release suspension for injection |
Triptorelin only product in parenteral dose form |
Triptorelin pamoate 3.75mg/vial powder |
Triptorelin only product in parenteral dose form |
Trisodium edetate allergy |
Allergy to edetate (finding) |
Tritiarchium |
Tritirachium |
Tritiarchium oryzae |
Tritirachium oryzae |
Trochanteric transplant |
Osteotomy and transfer of greater trochanter |
Trophic ulcer |
Neurogenic ulcer |
Tropicamide 0.5% conventional release eye drops |
Product containing precisely tropicamide 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Tropicamide 0.5% single-use eye drops |
Product containing precisely tropicamide 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Tropicamide 1% conventional release eye drops |
Product containing precisely tropicamide 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Tropicamide 1% single-use eye drops |
Product containing precisely tropicamide 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
Trout - dietary |
Trout (substance) |
True bug |
Order Hemiptera (organism) |
True histiocytic lymphoma |
Histiocytic sarcoma |
True yeast |
Order Saccharomycetales (organism) |
Trunk angiography NOS |
Angiography of blood vessel of trunk |
Trunk angiography NOS |
Angiography of blood vessel of trunk |
Trunk flap |
Flap (substance) |
Trunk soft tissue X-ray |
Plain X-ray of soft tissue of trunk (procedure) |
Trypan blue 0.06% ophthalmic solution |
Trypan blue stain only product |
Trypan blue 1.5mg/mL ophthalmic solution |
Trypan blue stain only product |
Trypanocides[no drugs here] |
Antiprotozoal |
Tryptase |
Tryptase |
Tsukamurella wratislaviensis |
Rhodococcus wratislaviensis (organism) |
Tubal abortion |
Miscarriage of tubal ectopic pregnancy |
Tubal-cornual placenta |
Cornual placenta accreta |
Tube feeding by Barron pump |
Enteral feeding |
Tuberculin PPD 100,000units/mL injection solution 1mL ampule |
Product containing precisely tuberculin purified protein derivative 100000 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tuberculin PPD 1:10,000(10units/mL) injection solution 1mL ampule |
Product containing precisely tuberculin purified protein derivative 10 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tuberculin PPD 1:100(1000units/mL) injection solution 1mL ampule |
Tuberculin purified protein derivative 1000 unit/mL solution for injection |
Tuberculin PPD 1:1000(100units/mL) injection solution 1mL ampule |
Product containing precisely tuberculin purified protein derivative 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tuberculin, purified protein 1u/mL injection solution vial |
Tuberculin purified protein derivative 50 unit/mL solution for injection |
Tuberculosis NOS |
Tuberculosis |
Tuberculosis NOS |
Tuberculosis |
Tuberculosis of cervical lymph nodes |
Cervical tuberculous lymphadenitis |
Tuberculosis of other female genital organs |
Tuberculosis of female genital organs |
Tuberculosis of other organs |
Tuberculosis |
Tuberculosis of other organs |
Tuberculosis |
Tuberculosis of other organs NOS |
Tuberculosis |
Tuberculosis of other specified bone |
Tuberculosis of bone |
Tuberculosis of other specified joint |
Tuberculous arthritis |
Tuberculosis of other specified joint |
Tuberculous arthritis |
Tuberculosis of other urinary organs |
Tuberculosis of urinary organs |
Tuberculosis of other urinary organs (disorder) |
Primary progressive tuberculosis |
Tuberculosis of peritoneum |
Tuberculous peritonitis |
Tuberculous |
Tuberculous (qualifier value) |
Tuberculous spondylitis |
Tuberculosis of vertebral column |
Tubular adenoma - category |
Benign tubular adenoma (morphologic abnormality) |
Tubular adenoma, no International Classification of Diseases for Oncology subtype |
Benign tubular adenoma (morphologic abnormality) |
Tumor grade GB |
American Joint Committee on Cancer grade GB (qualifier value) |
Tumor of uterine body affecting obstetric care |
Neoplasm of body of uterus in pregnancy, childbirth and puerperium |
Tumor stage T1a |
American Joint Committee on Cancer cT1a (qualifier value) |
Tumor stage T1a1 |
American Joint Committee on Cancer cT1a1 (qualifier value) |
Tumor stage T1a2 |
American Joint Committee on Cancer cT1a2 (qualifier value) |
Tumor stage T1b |
American Joint Committee on Cancer cT1b (qualifier value) |
Tumor stage T1b1 |
American Joint Committee on Cancer cT1b1 (qualifier value) |
Tumor stage T1b2 |
American Joint Committee on Cancer cT1b2 (qualifier value) |
Tumor stage T1c |
American Joint Committee on Cancer cT1c (qualifier value) |
Tumor stage T1mic |
American Joint Committee on Cancer cT1mi (qualifier value) |
Tumor stage T2a |
American Joint Committee on Cancer cT2a (qualifier value) |
Tumor stage T2b |
American Joint Committee on Cancer cT2b (qualifier value) |
Tumor stage T2c |
American Joint Committee on Cancer cT2c (qualifier value) |